SpyGlass Pharma, Inc. (NASDAQ: SGP) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SPYGLASS PHARMA, INC.

SpyGlass Pharma, Inc. (NASDAQ: SGP)
Listen to this Section

$22.63
+0.1100 ( +0.49% ) 157.7K

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Market Data
Open $22.63
Previous Close $22.52
Volume 157.7K
Market Cap $752.92M
Day Range $19.45 - $22.91
52 Week Range $17.06 - $32.44
Shares Outstanding 33.43M
Change % +0.49%
Net Change ▲ 0.1100
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
IPO Year2026
CountryUnited States
UnderwriterJefferies, Leerink Partners, Citi, Stifel, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings

No data available for selected period.

Latest News

About US

Services

Stay Connected